喉雷什曼病:意大利北部的一个被忽视的新兴疾病
Matteo Lazzeroni1, Serena Reato2, Spinello Antinori3
1Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Journal of voice : official journal of the Voice Foundation
|April 24, 2024
概括
莱什曼病是地中海地区一个新兴的威胁. 这一案例凸显了诊断和治疗喉雷什曼病的挑战,即使在免疫能力强的个体中也是如此,并引入了一种新的预防性治疗方法.
科学领域:
- 医学科学 医学科学 医学科学
- 寄生虫学的寄生虫学
- 公共卫生 公共卫生
背景情况:
- 莱什曼病是地中海国家日益严重的公共卫生问题,意大利北部的发病率正在上升.
- 导致这种增长的因素包括日益增长的免疫力低下的人口和潜在的气候变化.
- 喉雷什曼病虽然很罕见,但在诊断和治疗方面存在挑战.
研究的目的:
- 描述一个免疫能力强的患者中复发性喉雷什曼病的病例.
- 突出非特异性慢性喉炎所带来的诊断困难.
- 报告第一次使用喷雾化胺用于预防复发性喉雷什曼病的预防.
主要方法:
- 一个患有严重喘的女性患者在吸入类固醇的病例报告.
- 诊断基于临床表现和活检通过灵活的视频喉科镜.
- 治疗包括手术灵活的视频喉腔镜和预防性气溶 pentamidine.
主要成果:
- 患者出现了非特异性慢性喉炎,导致诊断延迟和多次复发.
- 手术灵活的视频喉腔镜可在没有全身麻醉的情况下进行活检,从而降低成本.
- 在这种情况下,预防性气溶 pentamidine 首次被使用.
结论:
- 喉雷什曼病需要高度的怀疑指数,即使在免疫能力强的患者中也是如此.
- 非特定的症状和缺乏治疗指南使管理复杂化.
- 喷雾胺可能为复发病例提供一个有前途的预防策略.
相关概念视频
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


